Research Newsletter - August 2024

Cancer center among top accruals for gynecologic studies

The cancer center’s gynecology group is now ranked No. 11 among the top 50 sites for GOG partners/NRG clinical study accrual. This ranking was shared by the GOG Foundation at the recent NRG Oncology meeting. The GOG Foundation is a nonprofit organization and collaborative network for transformative research in gynecologic malignancies.

Big Ten CRC Summit is Sept. 27

Registration is open for the Big Ten Cancer Research Consortium Summit, taking place at the Big Ten Conference Headquarters on September 27, 2024, in Rosemont, Ill. This event is geared towards senior and junior faculty and fellows involved in clinical oncology research, basic scientists involved in drug discovery and translational research, cancer center leadership and administration, industry leaders and medical science liaisons, and patient advocates.

Register now and secure your spot.

 

Member headlines and highlights

Nasser Hanna, MD (EDT), is featured in the ASCO President’s Corner. ASCO President Robin Zon, MD, asked him about End Lung Cancer Now, an initiative of the cancer center. Read the Q&A.

Misty Shields, MD, PhD (EDT), discusses the significance of the FDA approval of tarlatamab for patients with extensive-stage small cell lung cancer in an OncLive video and article.

Mark Kelley, PhD (EDT), discusses what makes APE1/Ref-1 a promising target for cancer therapy in a Drug Target Review article. Read the Q&A.

#ResearchCuresCancer

Support Our Research